Gamma delta (γδ) T cells hold significant potential for unmet medical needs. Yet they are more challenging to source than ...
MyChesCo on MSN12d
Century Therapeutics to Present Cutting-Edge Preclinical Data at 2024 ASH Annual MeetingPHILADELPHIA, PA — Century Therapeutics (NASDAQ: IPSC) is set to showcase groundbreaking advancements in its iPSC-derived ...
GammaDelta’s drug platform is based on the unique properties of gamma delta (γδ) T cells, a class of lymphocytes that play a role to many types of immune responses and immunopathology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback